PMID: 6109102Jan 3, 1981Paper

Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate

Lancet
D F MartinJ P Miller

Abstract

In a double-blind randomised trial in 75 patients with duodenal ulceration diagnosed endoscopically, 38 patients were given tripotassium dicitrato bismuthate and 37 cimetidine. There was no significant difference in the healing rates between the two drugs after 1 and 2 months, although relief of symptoms was marginally quicker with cimetidine. During follow-up for at least a year, relapse was significantly more common in patients whose ulcers had healed during treatment with cimetidine than in those whose ulcers had healed during treatment with tripotassium dicitrato bismuthate. This difference appears to be related to the medication rather than to any other difference between the two groups of patients. These results suggest that drug treatment given for a short period in duodenal-ulcer disease influences the progress of the disease.

Citations

Jan 1, 1989·European Journal of Clinical Pharmacology·P R FroomesA J McLean
Nov 1, 1985·Digestive Diseases and Sciences·G Bertaccini, G Coruzzi
Jun 1, 1987·World Journal of Surgery·D W Piper
Sep 1, 1995·Digestive Diseases and Sciences·M Jablonská
Jan 1, 1992·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·T P KemmerH Ditschuneit
Feb 13, 1999·Comprehensive Therapy·L F Brown, D E Wilson
May 1, 1993·Gastroenterologia Japonica·T Arakawa, K Kobayashi
Jun 9, 1989·The American Journal of Medicine·S K Lam
Apr 28, 1993·European Journal of Pharmacology·M ShibataH Ohnishi
Feb 15, 1996·European Journal of Pharmacology·T IchikawaK Hotta
Aug 25, 1990·Lancet
Mar 1, 1993·Baillière's Clinical Gastroenterology·M J Arens, J Dent
Mar 17, 1983·The New England Journal of Medicine·C E Welch, R A Malt
Dec 1, 1983·The New England Journal of Medicine·F P McKegney
Jul 20, 1995·The New England Journal of Medicine·D Y Graham, M F Go
Dec 1, 1989·Journal of Clinical Pharmacy and Therapeutics·B BradleyA Lin Wan Po
Jul 1, 1994·Journal of Gastroenterology and Hepatology·S K Lam, C K Ching
Feb 1, 1997·Journal of Gastroenterology and Hepatology·H NebikiK Kobayashi
Apr 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·P O ParkU Haglund
Aug 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·H Rautelin, T U Kosunen
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·C A McNultyR Wise
Sep 7, 1985·British Medical Journal·T V Taylor
Nov 1, 1986·British Medical Journal·J P Miller, E B Faragher
Jul 1, 1984·Gut·R E Pounder
Jan 1, 1987·Gut·C W Howden, R H Hunt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.